MPM Oncology Impact Management GP LLC, 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 34,318 shares at $20.26 ($694K) on 2021-05-27, disclosed to the SEC on 2021-05-27.
Open-market sale of $694k HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.04 | 3,198 | $64K | 9.2% |
| 2 | $20.04 | 3,198 | $64K | 9.2% |
| 3 | $20.26 | 13,961 | $283K | 40.8% |
| 4 | $20.26 | 13,961 | $283K | 40.8% |
| Total | $20.22 avg | 34,318 | $694K | 100% |
| Filing → |
| HARP | SELL | 2021-05-17 | $520K | — | Filing → |
| HARP | SELL | 2021-05-04 | $14.7M | — | Filing → |
| HARP | SELL | 2021-04-22 | $330K | — | Filing → |